IXALTIS IXALTIS
  • Home
  • Company
    • About us
    • Genito-urinary diseases
  • Governance
    • Board of Directors
    • Scientific Advisory Board
    • Management
  • R&D
    • Pipeline
    • Litoxetine (IXA-001)
    • IXA-002 & IXA-003
    • MAGenTA
  • Press
  • Contact

Press

Home / Press

 

18Oct201718 octobre 2017
Press Release, Ixaltis-IND, October 2017

Press Release, Ixaltis-IND, October 2017

Read More
In Press
06Oct20176 octobre 2017
Press Release, Ixaltis-Xigen, October 2017

Press Release, Ixaltis-Xigen, October 2017

Read More
In Press
15Avr201728 juillet 2017
Biotech Finance, Avril 2017

Biotech Finance, Avril 2017

Read More
In Press
04Mar201728 juillet 2017
Start of Phase 2 Clinical Trial, March 2017

Start of Phase 2 Clinical Trial, March 2017

Read More
In Press
03Mar201728 juillet 2017
Presentation of abstracts at EAU 2017, March 2017

Presentation of abstracts at EAU 2017, March 2017

Read More
In Press
27Fév201728 juillet 2017
Abstract 2/2 EAU 2017 – Effects of litoxetine on acetic acid-induced

Abstract 2/2 EAU 2017 – Effects of litoxetine on acetic acid-induced

Read More
In Press
27Fév201728 juillet 2017
Abstract 1/2 EAU 2017 – Effects of litoxetine on urethral pressure

Abstract 1/2 EAU 2017 – Effects of litoxetine on urethral pressure

Read More
In Press
18Juin201629 août 2017
24H, June 2016

24H, June 2016

Read More
In Press
09Juin201629 août 2017
Eco des Savoie, June 2016

Eco des Savoie, June 2016

Read More
In Press
08Juin201629 août 2017
Bref, June 2016

Bref, June 2016

Read More
In Press
06Juin201629 août 2017
Capital Finance, June 2016

Capital Finance, June 2016

Read More
In Press
02Juin201629 août 2017
FierceBiotech, June 2016

FierceBiotech, June 2016

Read More
In Press
  • 1
  • 2

IXALTIS

Archamps Technopôle, Acti'Tech 6, 60 avenue Marie CurieArchampsFrance74160
+33 (0)4 57 26 00 76

Find us

Website

Legal Mentions

IXALTIS © 2017 / All Rights Reserved